The role of Bcl6 in the differentiation and function of Tfh
Bcl6在Tfh分化和功能中的作用
基本信息
- 批准号:8125922
- 负责人:
- 金额:$ 1.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-02-01 至 2011-05-27
- 项目状态:已结题
- 来源:
- 关键词:AffectAntibodiesAntigensAutoimmune ProcessB-LymphocytesBLR1 geneBiologyBloodCD4 Positive T LymphocytesCancer BiologyCancer VaccinesCell LineageCellsCellular biologyDataEnsureGene ExpressionGeneral PopulationGenerationsGenesGerminal Center B-LymphocyteHelper-Inducer T-LymphocyteHumanHumoral ImmunitiesImmune responseImmune systemImmunizationImmunoglobulin GIndividualInterleukin-12InterventionKnowledgeLIF geneLicensingLupusLymphocyteLymphomaMalignant NeoplasmsMedicalMemoryMessenger RNAModelingMusNatureOncogenicPatternPlayProductionProteinsReportingRestRodentRoleScienceSignal TransductionStructure of germinal center of lymph nodeT-Lymphocyte SubsetsTCR ActivationTestingTherapeuticTonsilTranslationsVaccine DesignVaccinesWorkautocrinebasecost effectivecytokinedesignneutralizing antibodynovelnovel therapeutic interventionoverexpressionpathogenplasma cell differentiationresponsesmall hairpin RNAstemtranscription factorvector
项目摘要
DESCRIPTION (provided by applicant): The role of Bcl6 in the differentiation and function of follicular helper CD4 T cells Immunization is one of the most cost effective medical interventions. Most vaccines work through the generation of pathogen neutralizing antibodies made by B lymphocytes. However, these B cells cannot function properly without help from other immune system components. Another type of lymphocyte, the follicular T helper cell (TFH), is important for the generation of antibody producing B lymphocytes and germinal centers, yet TFH have only been recently discovered and their biology is not well understood. We have uncovered two transcription factors, Bcl6 and Blimp-1, that function as central regulators of TFH differentiation in mice (Science, 2009). Translation of these findings into humans will bridge critical gaps in our understanding of CD4 T cell lineage commitment and humoral immunity. By enhancing our knowledge of how these proteins control TFH differentiation and function in humans, we can ensure that vaccines are designed such that they utilize these cells to promote more effective immune responses. The ability to design immunizations in a more rational fashion will impact the traditional and cancer vaccine fields, and could enormously benefit the general population. Furthermore, because Bcl6 plays a crucial oncogenic role in many lymphomas, a more complete understanding of how Bcl6/Blimp1 control lineage commitment may bring about novel lymphoma therapies. Aim I of this proposal will investigate how Bcl6 regulates human TFH differentiation. Aim II will enhance our understanding of how LIF and other TFH cytokines affect TFH differentiation and function.
PUBLIC HEALTH RELEVANCE: The vast majority of currently licensed vaccines protect humans by triggering the production of pathogen neutralizing antibodies. Follicular T helper cells are a critical component of this humoral immune response, and our knowledge of how they differentiate and function is limited. A better understanding of follicular T helper cell biology will allow for more rational vaccine design and novel therapeutic approaches to certain cancers and autoimmune conditions.
描述(申请人提供):Bcl6在卵泡辅助性CD4 T细胞分化和功能中的作用免疫是最具成本效益的医疗干预措施之一。大多数疫苗通过产生B淋巴细胞产生的病原体中和抗体起作用。然而,如果没有其他免疫系统成分的帮助,这些B细胞无法正常工作。另一种类型的淋巴细胞,滤泡T辅助细胞(TFH),对产生抗体的B淋巴细胞和生发中心很重要,但TFH最近才被发现,其生物学尚不清楚。我们发现了两个转录因子,Bcl6和Blimp-1,它们在小鼠的TFH分化中起着中心调节作用(Science, 2009)。将这些发现转化为人类将弥合我们对CD4 T细胞谱系承诺和体液免疫的理解中的关键空白。通过加强我们对这些蛋白质如何控制人体内TFH分化和功能的了解,我们可以确保疫苗的设计能够利用这些细胞来促进更有效的免疫反应。以更合理的方式设计免疫接种的能力将影响传统和癌症疫苗领域,并可能极大地惠及普通民众。此外,由于Bcl6在许多淋巴瘤中起着至关重要的致瘤作用,因此更全面地了解Bcl6/Blimp1如何控制谱系承诺可能会带来新的淋巴瘤治疗方法。本文的目的一是研究Bcl6如何调控人TFH分化。Aim II将增强我们对LIF和其他TFH细胞因子如何影响TFH分化和功能的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark Kroenke其他文献
Mark Kroenke的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Rationally guided discovery platform for monoclonal antibodies against carbohydrate antigens using virus-like particle conjugate immunization and high throughput selection
使用病毒样颗粒缀合物免疫和高通量选择的合理引导的针对碳水化合物抗原的单克隆抗体的发现平台
- 批准号:
10574738 - 财政年份:2023
- 资助金额:
$ 1.71万 - 项目类别:
Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection
评估肝期抗原特异性抗体对抗恶性疟原虫肝期感染的作用
- 批准号:
10392870 - 财政年份:2021
- 资助金额:
$ 1.71万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
10092930 - 财政年份:2020
- 资助金额:
$ 1.71万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
9896170 - 财政年份:2020
- 资助金额:
$ 1.71万 - 项目类别:
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
使用进化遥远的海七鳃鳗结构独特的可变淋巴细胞受体抗体询问 B 谱系细胞上的细胞表面抗原
- 批准号:
433456 - 财政年份:2020
- 资助金额:
$ 1.71万 - 项目类别:
Operating Grants
Investigations of interactions between various natural antibodies and food-derived antigens
研究各种天然抗体与食物源性抗原之间的相互作用
- 批准号:
19K15765 - 财政年份:2019
- 资助金额:
$ 1.71万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identifying Kawasaki Disease-Specific Antibodies and Antigens
识别川崎病特异性抗体和抗原
- 批准号:
9932769 - 财政年份:2018
- 资助金额:
$ 1.71万 - 项目类别:
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
BB/P504713/1 - 财政年份:2017
- 资助金额:
$ 1.71万 - 项目类别:
Training Grant
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
1932904 - 财政年份:2017
- 资助金额:
$ 1.71万 - 项目类别:
Studentship
SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens
SBIR II 期:针对蛋白质和碳水化合物抗原的抗体的自动化设计方法
- 批准号:
1632399 - 财政年份:2016
- 资助金额:
$ 1.71万 - 项目类别:
Standard Grant